Corporate Action

The Senate's new Naloxone Awareness Day highlights a critical shift. As fentanyl rages, a life-saving drug is moving from ambulances to school hallways.

Artificial intelligence demands unprecedented, volatile power. Now, a new battle is on to define and build the 'AI-grade' infrastructure needed to fuel it.

The Canada Revenue Agency's 'Manage balance' service has processed $1.1B in debt, but does this digital shift truly help all Canadians?

New data reveals a 'Women CEO Effect'—companies led by women don't just break ceilings, they build entirely new pipelines for female leadership.

Cabot Corporation's sixth EcoVadis Platinum rating is more than an award; it highlights a crucial evolution in corporate accountability, ethics, and trust.

A $10,000 award to a future cyber defender is more than a press release. It's a look at how industry giants are tackling the global talent crisis.

A 200-year-old bank is partnering with Flare AI, ditching software licenses for guaranteed outcomes. This move could redefine how regulated industries adopt tech.

Beyond pandemic tools, this year's top innovators like Deel and Cloudbrink show remote work tech is now a core driver of global growth and security.

A health AI company is adding top cardiologists to its board, signaling a strategic shift to prove that algorithms can solve real-world health crises.

Beyond simple comfort, your next HVAC is a major investment. We break down the tech, costs, and policies shaping the heat pump, furnace, and hybrid debate.

Opodo's latest data reveals more than just destinations; it shows a strategic consumer shift. Brits are trading long-haul for value and impulse for planning.

As AI agents act with growing autonomy inside business tools, a new solution from MSPAlliance offers unprecedented visibility, shifting risk from a guess to a science.

As two trailblazing leaders conclude their terms, they leave a legacy of tech adoption and career support while navigating a complex new landscape for diversity.

Greenland Mines accelerates its Sarfartoq project, a vital source of Nd-Pr rare earths, aiming to secure a critical Western supply chain for EV and defense tech.

Memo Therapeutics' Potravitug shows promise in a Phase II trial, offering the first real weapon against a common virus that threatens kidney transplants.

RedHill Biopharma's new financing provides crucial cash, but the real story is in the warrants and the hunt for a strategic acquisition. A deep dive.

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

A massive conditional loan from the Pentagon's investment arm aims to transform a Utah uranium mill into a cornerstone of America's critical minerals strategy.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?

VinFast is betting big on the VF 8 with aggressive pricing, but a closer look reveals a high-stakes play to overcome range deficits and a rocky US start.